Bridget A. Martell
CIK: 0001629627
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2026ALGS
Aligos Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
5.9K shares- - May 13, 2026DCTH
DELCATH SYSTEMS, INC.
Award(A)DirectStock Option (right to buy)
22.5K shares- - Jun 25, 2025ALGS
Aligos Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
5.9K shares- - Jun 6, 2025ACHV
ACHIEVE LIFE SCIENCES, INC.
Award(A)DirectStock Option (right to buy)
31.5K shares- - May 15, 2025DCTH
DELCATH SYSTEMS, INC.
Award(A)DirectStock Option (right to buy)
22.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 | ALGS Aligos Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 5,860 | - | - | Direct |
| May 13, 2026 | DCTH DELCATH SYSTEMS, INC. | Award(A) Stock Option (right to buy) | 22,500 | - | - | Direct |
| Jun 25, 2025 | ALGS Aligos Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 5,860 | - | - | Direct |
| Jun 6, 2025 | ACHV ACHIEVE LIFE SCIENCES, INC. | Award(A) Stock Option (right to buy) | 31,500 | - | - | Direct |
| May 15, 2025 | DCTH DELCATH SYSTEMS, INC. | Award(A) Stock Option (right to buy) | 22,500 | - | - | Direct |
1-5 of 5 transactions
About Martell Bridget A
Martell Bridget A (SEC CIK 0001629627) files insider reports with the SEC as Director of Aligos Therapeutics, Inc. (ALGS), Director of DELCATH SYSTEMS, INC. (DCTH) and Director of ACHIEVE LIFE SCIENCES, INC. (ACHV).
Signal8 holds 5 ownership filings by Martell Bridget A, all Form 4s, filed between May 19, 2025 and Jun 29, 2026. Those filings report 5 transactions, from May 15, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Martell Bridget A's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Martell Bridget A
- Jun 25, 2026: Grant or award of ALGS derivative securities (Form 4, code A).
- May 13, 2026: Grant or award of DCTH derivative securities (Form 4, code A).
- Jun 25, 2025: Grant or award of ALGS derivative securities (Form 4, code A).
- Jun 6, 2025: Grant or award of ACHV derivative securities (Form 4, code A).
- May 15, 2025: Grant or award of DCTH derivative securities (Form 4, code A).
Other insiders filing for Aligos Therapeutics, Inc. (ALGS)
- Preston Heather, Director
- Chavez Margarita, Director
- Scopa James Paul, Director
- Nuechterlein Carole, Director
- Hirth Peter, Director
- Symons Julian A.